Bacterial Infections 07/02/2011 BY: MOHAMMED ALSAIDAN Normal skin flora NORMAL SKIN FLORA Class Organisms Aerobic cocci Staphylococcus aureus*, S. All body sites, especially saprophyticus, S. intertriginous areas epidermidis† , Micrococcus luteus, M. roseus, M. varians Corynebacterium Intertriginous areas (e.g. minutissimum, C. axillae, groin, toe webs) lipophilicus, C. xerosis, C. jeikeium, Brevibacterium epidermidis Propionibacterium acnes, Sebaceous glands and P. granulosum, P. avidum follicles Acinetobacter spp. Axillae, perineum, antecubital fossa Malassezia furfur Skin rich in sebaceous glands (e.g. scalp) Aerobic coryneform Anaerobic coryneform bacteria Gram-negative bacteria Yeast Location on body Impetigo • It is the most common bacterial infection in children • highly contagious, spreading rapidly via direct person-toperson contact • The primary pathogen is S.aureus and, less commonly, Streptococcus pyogenes • Non Bullous : usually at site of trauma • Bullous: (considered a localized form of SSSS) elaborates several exfoliative toxins (A–D), targeting desmoglein 1 acantholysis in granular layer mimicking P.folaceus Impetigo • Predisposing factors include • • • • • warm temperature, high humidity, poor hygiene atopic diathesis skin trauma (chickenpox, insect bite, abrasion, laceration, burn) S. aureus colonization Impetigo work up ? • Diagnosis is usually made clinically • Exudate from beneath the crust and fluid from intact bullae can be sent for culture and sensitivity • Leukocytosis in 50% Treatment • local wound care • Cleansing • removal of crusts • wet dressings • For healthy patients with a few, isolated superficial lesions and no systemic symptoms: • mupirocin 2% ointment or fusidic acid equally effective to oral antibiotics Folliculitis • Folliculitis: infection localized to the hair follicle • Furuncle: entire follicle and surrounding tissue are involved • carbuncle : multiple furuncles grouped together • S. aureus is the most common infectious cause of folliculitis • Gram-ve folliculitis A.V. treated with long courses of oral antibiotics • Pseudomonas folliculitis use of hot tubs Folliculitis • Factors predisposing • • • • • • • • • occlusion maceration and hyperhydration with hot and humid weather, shaving, plucking or waxing hair topical corticosteroids diabetes mellitus atopic dermatitis. Obesity Immunodeficiency Poor hygiene Folliculitis • Site: face, chest, back, axillae or buttocks • superficial folliculitis (Bockhart's impetigo) are small, 1–4 mm pustules or crusted papules on an erythematous base • Gram stain and bacterial cultures in recurrent or treatmentresistant cases Folliculitis treatment • Localized: • antibacterial washes • bacitracin or mupirocin 2% may also be used for 7-10 days • Widespread or recurrent: • appropriate β-lactam antibiotics, macrolides or clindamycin • Chronic S. aureus carriage • mupirocin 2% ointment applied twice daily to the nares, axillae/groin and/or submammary area for 5 days. Furuncles, Carbuncles • S. aureus is the most common causative organism • Furuncles usually begin as a hard, tender, red nodule that enlarges and becomes painful and fluctuant; rupture results in decreased pain, Systemic symptoms are usually absent Furuncles, Carbuncles • Carbuncles are collections of furuncles that extend deep into the subcutaneous tissue. • The surface usually displays multiple draining sinus tracts and occasionally ulcerates. • They usually occur in areas with thicker skin (e.g. nape of neck, back, thigh) • Systemic symptoms are usually present. • Carbuncles are slow to heal scar formation Treatment • simple furuncles: • warm compresses may promote maturation, drainage and resolution of symptoms • Fluctuant lesions • incision and drainage • Systemic antibiotics should be used in four instances: • (1) furuncles around the nose, within the nares or in the external auditory canal • (2) large and recurrent lesions • (3) lesions with surrounding cellulitis • (4) lesions not responding to local care MRSA • Furunculosis is the most frequently reported manifestation of community acquired MRSA • MRSA can manifest as : • abscesses or frank cellulitis • impetigo, bullous impetigo, scalded skin syndrome, nodules or pustules • bacteremia, septic shock and a toxic shock-like syndrome • The major cause of methicillin resistance is the production of an altered (i.e. reduced affinity) penicillin-βinding protein (PBP) called PBP2a Treatment • Emperical treatment with Vancomycin is indicated in : • patients with severe, life-threatening infection • in patients with a history of MRSA colonization • in intravenous drug users Blistering Distal Dactylitis • children aged 2-16 years • Presents as a localized infection of the volar fat pad of a finger or a toe • Blister formation and involvement of the nail fold or more proximal portion of the digit • Darkening of the surrounding skin before blister formation Blistering Distal Dactylitis • Group A β-hemolytic Streptococcus, S. aureus and, rarely, S. epiermidis are the responsible organisms DDx: • herpetic whitlow • thermal or chemical burn • acute paronychia • bullous impetigo (vesicles more superficial) • frictional bullae Blistering Distal Dactylitis Treatment • Incision and drainage plus • a 10-day course of an oral antistaphylococcal antibiotic (e.g. cephalexin) can prevent development of new sites of infection as well as local extension. Ecthyma • Considered as : ulcerated form of non-bullous impetigo like lesion • due to either a primary infection with Str. pyogenes or streptococcal superinfection of a pre-existing ulceration Staphylococcal Scalded Skin Syndrome • Staphylococcal toxin-mediated infections includes: • ssss • bullous impetigo • toxic shock syndrome • Exfoliative toxins (ETs) ETA and ETB are serine proteases with a very high specificity for human desmoglein 1 (DG-1) Staphylococcal Scalded Skin Syndrome • Increased frequency of staphylococcal scalded skin syndrome in children younger than 5 years due to : • Absence of antibodies specific for exotoxins • Immature renal function in this age group may impair clearance • The relative quantity of DG-1 in the skin differs with age SSSS clinical features Clinical features: • • • • • Prodrome Severe tenderness of the skin Erythema Flaccid bullae within the superficial epidermis. In 1-2 days, the bullae are sloughed moist skin and areas of thin, varnish-like crust. SSSS clinical features • The flexural areas are the first to exfoliate. • Scaling and desquamation continue for 3-5 days • Re-epithelialization in 10-14 days, without scarring • The Nikolsky sign is positive. • The mortality rate is 3% for children, over 50% in adults, and almost 100% in adults with underlying disease SSSS work up • Cultures taken from intact bullae are negative • Blood cultures are almost always negative in children, but may be positive in adults • The leukocyte count may be elevated or normal • Electrolytes and renal function should be followed closely in severe cases • PCR serum test for the toxin is available. SSSS work up • Biopsy: separation of the epidermis at the granular layer. An inflammatory cell infiltrate is typically not present • Negative IF • In (TEN), inflammatory (lymphocytic) infiltrate is present, and the plane of separation is deeper, at the level of the basement membrane. DDx • • • • • sunburn drug reaction Kawasaki disease extensive bullous impetigo viral exanthem, toxic shock syndrome, GVHD, TEN and pemphigus foliaceus. SSSS treatment • Localized disease : • Oral treatment with a β-lactamase-resistant antibiotic e.g.dicloxacillin, cloxacillin, for a minimum of 1 week • Emollient • Isolation • treatment of S. aureus carriers • Extensive, generalized forms of SSSS • hospitalization and parental antibiotics. Toxic Shock Syndrome • It is a multisystem disease caused by an exotoxin produced by S. aureus toxic shock syndrome toxin-1 (TSST-1). In the absence of antibodies against TSST-1. TSST-1 • Dermatologic manifestations are more extensive and predictable in staphylococcal TSS than in streptococcal TSS. Toxic Shock Syndrome • Sudden onset of high fever with myalgias, vomiting, diarrhea, headache and pharyngitis • Diffuse macular erythroderma > scarlatiniform eruption with flexural accentuation • Erythema and edema, then Delayed desquamation of palms and soles • Hyperemia of conjunctiva and mucous membranes • Strawberry tongue • After recovery, Beau's lines, telogen effluvium may occur DDx: • • • • • SSSS scarlet fever early TEN Kawasaki disease Rocky Mountain spotted fever Treatment • Remove Foreign bodies and any source of infection • Beta-lactamase-resistant antibiotics or antibiotics that suppress toxin production, such as clindamycin, rifampin or fluoroquinolones. • In severe cases of shock unresponsive to antibiotics, lowdose corticosteroids Severe cases of TSS : • intensive supportive therapy (intravenous fluids and vasopressor agents). Streptococcal Toxic Shock Syndrome • Rapidly progressive, often fatal illness • Toxins act as superantigens and can cause stimulation of T cells By binding to the class II MHC of APC • Most common initial symptom is severe local pain in an extremity • Mortality 30 to 60% • Severe complications of streptococcal TSS include renal failure, DIC , and adult RDS Streptococcal Toxic Shock Syndrome • Most cases require intensive supportive therapy with aggressive intravenous fluid and vasopressors. • Clindamycin inhibit the production of bacterial toxins (the cause of shock) and is the first-line treatment. • Early surgical intervention e.g. debridement or fasciotomy can be life-saving Scarlet Fever • Between 1 and 10 years of age • >10 years antibodies prevent rash but not the sore throat • Caused by toxins types A, B and C by group A streptococci • Lead to a delayed-type hypersensitivity reaction Clinical features • Prodrome • Rash appears 12–48 hours after the fever. • The rash starts as erythema of the neck, chest and axillae, and behind the ears. • After 4-6 hours, the remainder of the body is involved • spares the face , but cheeks may have flushing (although some circumoral pallor is characteristic). Clinical features • Pastia lines (where the rash runs together in the armpits and groin) appear and can persist after the rash is gone • The rash: tiny papules on an erythematous background– blanches with pressure • It resembles a ‘sunburn with goose pimples’ and feels like sandpaper Extracutaneous manifestation • The throat is red and edematous and develops an exudate after 3-4 days • There is tender cervical adenopathy and palatal petechiae. • The tongue is initially white with bright red papillae, but later becomes beefy red (‘red strawberry tongue’). • After 7-10 days, desquamation affecting the hands and feet Clinical features • Complications of scarlet fever include • • • • • • • • • • Otitis Mastoiditis Sinusitis Pneumonia Myocarditis Meningitis Arthritis Hepatitis Acute glomerulonephritis Rheumatic fever Scarlet fever work up • CBC: elevated leukocyte count with a left shift, mild hemolytic anemia with reticulocytosis can occur. • Nose and throat cultures will grow group A streptococci. • Detection of antistreptolysin O (ASO), antihyaluronidase, antifibrinolysin and anti-DNase B antibodies are useful in detecting the streptococcal infection. • Early in the disease, a mild albuminuria and hematuria can be seen. Scarlet fever work up • The differential diagnosis of scarlet fever includes • • • • • • hypersensitivity reaction to drugs Measles Rubella toxic shock syndrome SSSS Kawasaki disease and toxin-mediated erythema. Treatment • penicillin is the drug of choice (10-14-day course) • Antibiotic treatment as long as 10 days after the onset of symptoms will prevent the development of rheumatic fever. • Erythromycin can be used in penicillin-allergic patients. Erysipelas • It is an infection of the dermis with significant lymphatic involvement • Caused by infection with: • • • • • • group A streptococci and less often by S. aureus, Pneumococcus species, Klebsiella pneumoniae, Yersinia enterocolitica, Haemophilus influenzae type Erysipelas Clinical features • Abrupt onset of prodrom (clearly demarcated erythematous plaque) hot, tense, tender and indurated with non-pitting edema • The lower extremity is the most common location • LAP , with or without lymphatic streaking. • Pustules, vesicles, bullae and small areas of hemorrhagic necrosis may also form. • When the infection resolves, desquamation and postinflammatory pigmentary changes may occur Erysipelas Work up • Elevated leukocyte count with a left shift. • Blood cultures are positive in only about 5% of cases. • Swabs from local ports of entry, pustules or bullae, the throat, and the nares may be helpful. • Anti-DNase B and ASO titers are good indicators of streptococcal infections. Erysipelas Treatment • The treatment of choice is 10-14-day course of penicillin • Erythromycin in penicillin-allergic patients • Hospital admission and I.V or I.M. antibiotics for children and debilitated patients. • prophylaxis with daily penicillin for Recurrent erysipelas Streptococcal Intertrigo • Sharply demarcated, erythematous patches or thin plaques are observed in an intertriginous zone • Distinct, foul smell is suggestive. • Infants are particularly vulnerable due to irritation and frictional forces in moist deep skin folds of the neck, axillae, antecubital and popliteal fossae, and inguinal region. • Discrete psoriasiform lesions may also be seen. • group A streptococci >>> S. aureus and Proteus mirabilis. Streptococcal Intertrigo • The differential diagnosis includes • cutaneous candidiasis • seborrheic dermatitis • irritant contact dermatitis. • Simple intertrigo responds to measures that reduce friction and minimize moisture • A 10-day course of oral penicillin is effective in most instances, with failure of conservative methods Streptococcal Perianal Disease • Due to Str. pyogenes • Sharply demarcated, bright, perianal erythema extending 2– 3 cm around the anal verge • Patients may complain of painful defecation, blood-streaked stools, prolonged perianal irritation or pruritus soiling of undergarments. • Systemic symptoms are absent. • The infection may be preceded by a pharyngitis and should always be considered in patients with guttate psoriasis Streptococcal Perianal Disease DDX • candidiasis, seborrheic dermatitis, pinworm infection, inflammatory bowel disease, child abuse, and the early phase of Kawasaki disease. Rx: • 10-14-day course of penicillin or erythromycin. • After treatment, the area should be recultured to exclude recurrence Cellulitis • Cellulitis is an infection of the deep dermis and subcutaneous tissue • most commonly Str. pyogenes and S. aureus • In childhood S. aureus >>>> H. influenzae • Diabetic ulcers and decubitus ulcers ( Gram+ve cocci and Gram-ve and anaerobes) • immunocompetent via break in the skin barrier • immunocompromised bloodborne route is most common Cellulitis clinical features • Systemic symptoms: fever, chills and malaise. • 4 cardinal signs of inflammation: rubor (erythema), calor (warmth), dolor (pain), and tumor (swelling). • The lesion usually has ill-defined, non-palpable borders. In severe infections, vesicles, bullae • Pustules ,necrotic tissue, ascending lymphangitis and regional lymph node involvement may occur. Cellulitis clinical features • Children head and neck region • Adults extremities • I.V. drug abusers the upper extremities • Complications include • • • • acute glomerulonephritis (streptococci) Lymphadenitis subacute bacterial endocarditis. Damage to lymphatic recurrent cellulitis Cellulitis LABs: • WBC is usually normal or only slightly elevated. • Blood cultures are almost always negative except H. influenzae • In children and immunocompromised patients, needle aspiration and skin biopsy may be appropriate for atypical organisms DDx : • DVT, stasis dermatitis, superficial thrombophlebitis, panniculitis (especially lipodermatosclerosis) • pseudocellulitis Cellulitis treatment • Immobilization and elevation, application of wet dressings to areas with exudate. • Mild cases 10-day course of an oral antibiotic that cover . Str. pyogenes and S. aureus • Seriously ill or facial cellulitis Hospitalization and I.V antibiotics • Diabetic or decubitus ulcers broad-spectrum coverage (e.g. piperacillin/tazobactam or metronidazole plus ciprofloxacin) • Antibiotics adjusted according to cultures and sensitivities results • NO NSAIDs Pyomyositis • A primary bacterial infection of the skeletal muscles, most commonly by S. aureus , untreated disease can progress to septicemia and septic shock • Associated with HIV infection, I.V. drug abuse, immunosuppression and DM Clinically : • Myalgias and low-grade fever, progressive over 1-2 weeks ‘woody’ induration on palpation • Muscle abscess formation in the second stage of disease, and frank septicemia may follow. Pyomyositis Work up • MRI as soon as pyomyositis is suspected. • some cases can be confirmed by ultrasound-guided aspiration. DDx • Cellulitis, hematoma, dermatomyositis/polymyositis, HIVassociated myopathies, DVT, osteomyelitis, septic arthritis, and necrotizing fasciitis Rx • Surgical incision and drainage, I.V. antibiotics until clinical improvement followed by oral antibiotics for a total of 3 weeks Botryomycosis • Chronic, purulent and granulomatous bacterial infection, most commonly caused by S. aureus. • Cutaneous botryomycosis presents as cutaneous and subcutaneous nodular masses, abscesses, ulcers or verrucous plaques. +/– multiple sinuses and fistulae • Most patients have localized disease on the extremities and it may be preceded by trauma Botryomycosis • The lesions can involve the underlying muscle or bone • Systemic symptoms are infrequent • The lungs are the most common extracutaneous site of involvement, but any organ can be affected Botryomycosis biopsies • Biopsy reveal a chronic non-specific inflammatory reaction with fibrosis. Foreign body type giant cells are commonly seen. • 1–3 mm granular bodies which have basophilic centers representing bacteria, cells and debris. • The periphery has a homogeneous, eosinophilic, hyaline appearance secondary to a host immunoglobulin response (Splendore–Hoeppli phenomenon). • The granules stain easily with PAS, Gram and Giemsa stains. At high power, the center of the concretion consists of basophilic granular material. A brightly eosinophilic band encases the bacteria. Botryomycosis work up • Microscopic examination (fresh mount or 20% KOH) will show coarse granules with club-like projections. • Gram staining of crushed granules will usually display masses of staphylococci. • Bacterial and fungal cultures should be performed. • DDx: mycetoma, actinomycosis,, abscesses, dimorphic fungal infections, orf, tuberculosis and atypical mycobacterial infections Treatment • Excision and debridement. • Antibiotics usually do not penetrate the lesion adequately. • The CO2 laser used successfully. Necrotising Fasciitis • is essentially a ‘severe inflammation of the muscle sheath that leads to necrosis of the subcutaneous tissue and adjacent fascia, that is difficult to diagnose early and difficult to manage effectively. Types Risk factors for NF • • • • • • • >50 years of age Diabetes mellitus Peripheral vascular disease Intravenous drug use Alcoholism Immunosuppression Obesity GASNF and GAS toxic shock syndrome (STSS) • 50% of type II NF cases are associated with STSS. • STSS is an exotoxin-driven disease that significantly increases the mortality of streptococcal NF alone from <40% to 67% with up to half of patients needing amputation Clinical diagnosis of NF • Hx: • • • • • • • minor trauma insect or human bites recent surgery skin infection or ulcers injection sites and illicit intravenous drug usage Many cases, however, remain idiopathic Clinical diagnosis of NF • Hx: • foreign travel >>> resistant or unusual organisms • trauma involving soil contamination >>> fungal • Raw seafood ingestion or wound exposure to seawater >>> Vibrio spp. • tonsillitis, impetigo, or recent non-steroidal anti-inflammatory agent (NSAID) >>> streptococcal infection Clinical diagnosis of NF • Severe pain precedes skin changes by 24 to 48 h in >97.8% of patients • Mild erythema, cellulitis or swelling overlying the affected area. • tender area >> smooth, swollen area of skin with distinct margins progressing to dusky blue/purple, ‘bruising’ violaceous plaques, and finally full thickness necrosis with haemorrhagic bullae Radiology • US findings correlate reasonably well with histological fat changes in NF • T2-weighted images on MRI are probably the best radiological adjunctive investigation, but are more sensitive than specific Labs • Blood cultures are positive in 11 to 60% of patients with GASNF • Haemoglobinuria is common in GASNF • Blister fluid is often sterile. • Tissue biopsy is the investigation of choice for stain and C/S • Disseminated intravascular coagulation and thrombocytopenia are common Labs • ARF • CRP levels of >16 mg/dL, with a sensitivity of 89% and specificity of 90%, have been reported • Raised serum creatinine kinase (CK) indicates myositis or myonecrosis Labs • CK levels of 600 U/L gave a sensitivity of 58% and a specificity of 95% for cases of NF. • 30% hypocalcaemic • Hypoalbuminaemia and hyponatraemia • high serum lactate with severe metabolic acidosis The LRINEC (Laboratory Risk Indicator for Necrotising Fasciitis) The LRINEC (Laboratory Risk Indicator for Necrotising Fasciitis) • A score of 6 >> raises the suspicion • A score 8 >> ‘strongly predictive’ of NF • Predict mortality Histopathology • Deep incisional biopsies are more useful than punch biopsies • Biopsy should include the advancing edge and central necrotic areas • Histological examination reveals underlying thrombi, necrosis, polymorphonuclear infiltrate, microorganisms, and vasculitis. • Gram staining is important, since a paucity of leucocytes in the presence of Grampositive cocci may be seen in GASNF or CAMRSA due to leucocidin mediated destruction of WBCs. Management Surgical • Prompt diagnosis • Aggressive surgery removes the source of infection and toxins • (VAC) dressing with a continuous pressure of 40 to100 mmHg is useful for wound coverage and encourages granulation • the tissue oxygen tension can be measured with a probe using transcutaneous soft tissue oximetry. lower in NF than cellulitis Role of hyperbaric oxygen (HBO) • HBO switches off a-toxin production from Clostridium spp • increase the bactericidal action of neutrophils • Decrease mortality to 12% Antibiotics • Broad-spectrum empirical therapy covering most types of NF • Then >> based on culture data. • Clindamycin: switching off exotoxin production even in stationary phase organisms Empirical protocol • I.V. clindamycin 1.2 to 1.8 g six-hourly with I.V. imipenem 0.5 to 1 g six-hourly. • IF MRSA : I.V. linezolid 600 mg BID or daptomycin 6 mg/kg may be added in preference to vancomycin • For Vibrio spp. >> doxycycline 100 mg twice daily plus intravenous ceftazidime 2 g eight-hourly is recommended I.V.I.G • IVIG may • promote clearance of GAS by the immune system • neutralise streptococcal superantigens • act as an immunomodulatory agent • contraindication • selective IgA deficiency • history of anaphylaxis with immunoglobulins. • 2 g/kg, with the option of a second dose if necessary after 24 h. rate of 20 mL/h, increasing incrementally after 10 min to a maximum of 160 mL/h. prognosis • Bad prognostic factors: Not type 1 myonecrosis or myositis STSS High serum lactate combined with low sodium Late operation % BSA Acidosis Peripheral vascular disease Advanced age Other comorbidities Antimicrobial prophylaxis for contacts of GASNF • 27% of household contacts may be GAS carriers (200 times more likely to occur) • CDC, do not recommend routine testing for GAS colonisation or administration of chemoprophylaxis to household contacts. • UK Health Protection Agency in 2004, recommend prophylaxis to mothers and babies if either was infected during the neonatal period • Household contacts should be informed about the clinical manifestations of pharyngeal and GAS infection